Nephrotrans (Sodium Hydrogen Carbonate)

When ingested, sodium hydrogen carbonate dissociates into sodium and bicarbonate ions. The bicarbonate binds hydrogen ions, forming carbonic acid, which quickly converts to water and carbon dioxide, thereby raising the pH of gastric contents, urine, or systemic fluids and reducing acidity.

The appropriate dose of Nephrotrans is determined by a qualified healthcare professional based on the specific condition, patient age, renal function and other factors. Patients should follow the prescriber’s instructions and not self‑adjust the dosage.

Safety data for sodium hydrogen carbonate in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing Nephrotrans to pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nephrotrans provides bicarbonate ions that directly neutralise acid, whereas many antacids contain calcium or magnesium salts that also supply additional minerals. Sodium hydrogen carbonate offers rapid pH elevation but may increase sodium load, making it suitable for specific clinical scenarios such as metabolic acidosis.

Nephrotrans should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.

Nephrotrans is taken orally, usually as a tablet or powder that is dissolved in water, according to the prescribing clinician’s directions. It should be swallowed with a full glass of water unless otherwise instructed.

Serious risks include metabolic alkalosis, severe electrolyte disturbances such as hypokalemia or hypernatremia, and rare allergic reactions. Patients should be monitored for symptoms like muscle weakness, irregular heartbeat, or swelling and seek medical attention if they occur.

Nephrotrans is contraindicated in individuals with known hypersensitivity to sodium hydrogen carbonate, severe renal impairment, uncontrolled hypertension, or conditions where excess sodium intake is harmful. A healthcare professional should assess suitability before use.